Hangxiang Zhang

433 citations
10 papers · 380 indexed · h-index 8
Topics
Apelin-related biomedical research (3 papers)Paraoxonase enzyme and polymorphisms (2 papers)Nuclear Receptors and Signaling (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Hangxiang Zhang

10 papers receiving 379 citations

Peers

Hangxiang Zhang
Comparison fields: 5 of 67
  • Molecular Biology 157
  • Epidemiology 110
  • Cardiology and Cardiovascular Medicine 77
  • Physiology 71
  • Immunology 58
Replace Jun-shan Liang with:
Jun-shan Liang United States
Lander Egaña-Gorroño United States
Star Seyedkazemi United States
Cameron S. Brand United States
Yasunori Nio Japan
Xiaohong Yan China
Jiazhen Jiang China
Markus Blaess Germany
Christina Gaspar Villela Brazil
Mikiya Tokui Japan
Hangxiang Zhang relative to Jun-shan Liang United States Jun-shan Liang's profile →
Citations per field
00.5×1.5×2.3×
Jun-shan Liang · 1×
Citations per year

Countries citing papers authored by Hangxiang Zhang

Since Specialization
Citations

This map shows the geographic impact of Hangxiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangxiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangxiang Zhang more than expected).

Fields of papers citing papers by Hangxiang Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangxiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangxiang Zhang. The network helps show where Hangxiang Zhang may publish in the future.

Co-authorship network of co-authors of Hangxiang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Hangxiang Zhang. A scholar is included among the top collaborators of Hangxiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangxiang Zhang. Hangxiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 27
3 62
4 34
5 18
6 2
7 80
8 65
9 48
10 43

About Hangxiang Zhang

Hangxiang Zhang is a scholar working on Clinical Biochemistry, Virology and Pharmacology, having authored 10 papers that have together received 380 indexed citations. Recurring topics across this work include Apelin-related biomedical research (3 papers), Paraoxonase enzyme and polymorphisms (2 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Virology (39 citations), Cardiology and Cardiovascular Medicine (77 citations) and Epidemiology (110 citations). Hangxiang Zhang has collaborated with scholars based in China and United States. Frequent co-authors include Xin L., Walter J. Koch, Erhe Gao, Hui Zhang, Xiuqing Huang, Jialing Huang, Xinliang Ma, Tao Shen, Yong Man and Ling Tao. Their work appears in journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026